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Background: Kawasaki disease (KD) is the leading cause of acquired heart 
disease in developed countries. Reported incidences vary worldwide but 
incidence of KD has not been established in Portugal.
Aim: The aims of the study were to describe the epidemiologic characteristics 
and estimate incidence rates of KD among hospitalized children in Portugal.
Methods: This study was a descriptive, population-based study, which used 
hospital discharge records of patients <20 years of age diagnosed with KD from 
the Hospital Register database for 2000–2011. Incidence rates were calculated 
using the number of KD patients and corresponding National census data.
Results: There were 533 hospitalizations of 470 patients with KD as the 
primary diagnosis in Portugal, 63 hospitalizations were transfers of patients 
between hospitals and there were no relapses. The mean age at admis-
sion was 2.8 years, with male predominance (male-to-female ratio: 1.6:1). 
Children <5 years and infants <1 year represented 83% and 23% of all the 
patients admitted, respectively. Mean annual incidence was 6.5 per 100,000 
children <5 years, 4.5 per 100,000 infants <1 year and 7.8 per 100,000 
infants 1–4 years. We found considerable differences between national ter-
ritorial regions, with majority of cases in most dense regions. The mean 
length of hospital stay was 9 days, and the incidence peaked in spring (35%) 
and spring/winter (63%). Coronary aneurysms were reported in 8.5% of 
patients with a higher male-to-female ratio (3.4:1) and a lower mean age 
(1.93 years). Reported mortality was 0.4%.
Conclusions: This is the first large-scale epidemiologic study of KD in Por-
tugal. The highest incidences occurred among male children 1–4 years of 
age and in spring/winter.
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Kawasaki disease (KD) is an acute febrile illness with multisys-temic vasculitis that predominantly occurs in children under 5 
years of age and has a male predominance. The disease was first 
described in 1967, in Japan by Tomisaku Kawasaki, and has now 
been reported worldwide in all ethnic and racial groups but with 
significant differences in incidence rates.1–6
KD is the leading cause of acquired heart disease in 
 developed countries. The main complication of this rare dis-
ease is cardiac involvement and development of coronary artery 
aneurysms (CAA), which can evolve into stenosis and occlusion, 
which are the leading cause of myocardial infarction in children. 
The treatment with high-dose intravenous immunoglobulin within 
10 days after disease onset changes its outcome, decreasing signifi-
cantly the incidence of CAA up to 25% in untreated patients and up 
to 5%–15% in patients who were adequately treated.6–9
The etiology of the disease remains unknown, despite 4 
 decades of research. Antecedent respiratory illness and exposure 
to rug cleaning have been previously associated with KD. Neither 
of these or other environmental risk factors have been consistently 
identified as contributors to the disease.8,9
The leading hypothesis is that KD reflects an abnormal 
inflammatory response to one or more infectious triggers and envi-
ronment factors in genetically susceptible individuals. The genetic 
predisposition is supported by the striking difference in annual 
incidence between children of Asian (69–222 per 100,000 children 
<5 years of age) and European descent (4–15 per 100,000 children 
<5 years of age), which remains higher when Asian descendent 
children live in occidental countries.9–13
The first case of KD in Portugal was reported in 198114; to 
date several case reports and small retrospective studies have been 
published in Portugal, assuming incidence rates on limited and 
biased data that do not reflect the national incidence. In 2001, the 
Portuguese Pediatric Society started a Pediatric surveillance unit 
for KD. Although many clinicians have reported their cases, it was 
considered that the adherence to the surveillance was suboptimal, 
and it was not possible to complete an epidemiologic study.14–20
Recently, we started an extended study protocol for KD 
patients follow-up, specially focused on long-term cardiovascular 
sequelae, endothelial function and precursors of atherosclerosis 
evaluation. The lack of accurate data on epidemiology and inci-
dence of KD in Portugal was an important factor, which strongly 
supports this study.
Several previous studies have demonstrated that hospital 
discharge data are suitable for KD epidemiology surveillance and 
for providing estimates of KD incidence, once the vast majority of 
children with KD are hospitalized worldwide and also in Portu-
gal.10,21–24 In this study, the authors analyzed data from the national 
database of hospital discharge diagnostic codes regarding hospi-
talized children classified with KD code for a period of 12 years. 
Using these data, we estimated the number of the KD hospitaliza-
tions, the number of patients with the disease and the mean annual 
incidences of KD among children in Portugal.
MATERIALS AND METHODS
Hospital Discharge Records
In Portugal, the diagnosis-related groups (DRGs) classi-
fication system was officially established in 1990 for obtaining a 
concise and accurate summary of the case history. This classifica-
tion system allows a systematic and economic way of collecting the 
main information included in the case history and checking their 
quality. This coding system is mandatory and official for every 
patient discharged from all public hospitals nationwide. The DRGs 
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form is coded and includes both clinical and procedural aspects of 
hospitalization. DRGs are coded using the International Classifica-
tion of Diseases, 9th revision, Clinical Modification Code system.22
In this study, the national DRG database was retrospectively 
searched for code 446.1 of the International Classification of Dis-
eases, 9th revision, Clinical Modification Code: Kawasaki disease, 
over the period from 2000 to 2011. Hospital discharge records data 
were extracted, and we examined KD-associated hospitalizations by 
number of patients, age group, gender, outcome, hospital stay and 
region. Accompanying diagnoses were also analyzed, especially 
cardiac complications. Because data are based on hospitalization 
records, some variables (ethnic/race; immunoglobulin administra-
tion) were missing. Patients who had more than 1 record for the 
same episode or were admitted to one hospital and transferred to 
another were considered only once, and included in the region of 
the initial admission and the admission age was considered that 
of the first hospitalization.22 The study was approved by the ethics 
committee of the hospital.
Patients were stratified into 4 groups according to their age 
of admission: <5, 5–9, 10–14 and 15–19 years of life. Children <5 
years of age were further stratified into 2 subgroups: <1 and 1–4 
years of age. Five of the 7 territorial regions of Portugal were con-
sidered: North, Center, Lisbon, Alentejo and Algarve, representing 
continental regions; data on Atlantic islands of Madeira and Azores 
were not included.
Hospitalization rates and estimates of annual incidence 
were expressed per 100,000 children, using the 2011 national 
census estimates (Instituto Nacional de Estatística—Statistics 
Portugal) stratified for the same age groups and territorial units; 
it was possible to evaluate the number of cases per 100,000 
inhabitants stratified by age groups, gender and territorial units 
(Table, Supplemental Digital Content 1, http://links.lww.com/
INF/C614).23
Statistics
Statistical analysis was performed using the Statistical Pack-
age for Social Sciences, version 20.0 (SPSS, Chicago, IL), for Win-
dows. Data are expressed as mean ± standard deviation (SD), mean 
with range or number with percentage as appropriate. Descriptive 
statistics were performed on the demographic characteristics.
RESULTS
Overall
During the period from 2000 to 2011, a total of 533 hospi-
talizations were registered for 470 individuals <20 years of age in 
Portugal on database for hospitalizations of KD patients, 63 hos-
pitalizations were transfers between hospitals and there were no 
relapses. Of these individuals, 393 patients were stratified into the 
group with children <5 years of age corresponding to 83.4% of 
the sample and 109 patients were stratified into the subgroup with 
children <1 year old (23%).
The mean age at admission of all patients was 2.8 years 
(ranged from 2.4 to 3.8 years in 2007 and 2003, respectively). The 
mean age was lowest in Alentejo (1.7 years) and highest in the 
North (3.5 years) territorial regions.
Sixty-one percent of patients (287/470) were male, ratio 
1.6/1 (P = 0.0003), ranging from 1.2/1 in the North to 1.8 and 1.7/1 
in Center and Lisbon regions, respectively (Table 1). Considering 
the stratified age groups and subgroups, infants <1 year of age had 
the highest male-to-female ratio, 1.8:1, and children <5 years of 
age had a ratio similar to that of the whole sample. The mean age of 
hospitalization differed between boys and girls, but without statisti-
cal significance (27 and 33 months, respectively, P = 0.1).
We also found variations in territorial patient distribution, 
with the majority of cases in the more populated regions: more than 
half of the patients were hospitalized in the Lisbon region (58.9%); 
the lowest number of hospitalizations occurred in the south regions 
of the country (Algarve and Alentejo 2.1% and 4.0%, respectively); 
the North and the Center accounted for the identical admission 
rates of 17.4%.
The mean length of hospital stay was 9 days, ranging from 
1 to 110 days; the incidence peaked in spring (35%) and during 
spring/winter (63% of cases). During the study period, there was an 
average of 39 new patients with KD per year, and 4 peaks of total 
hospitalized patients: 2000 (47); 2004 (50); 2008 (46) and 2011 
(45) (Table 1).
Cardiac involvement was reported in 12.9% of patients 
(61 patients), with a male-to-female ratio of 3.1:1 (P = 0.001) 
and a mean age of 2.41 years (from 1.5 months to 8 years). 
The most frequent cardiac lesion was development of coro-
nary aneurysms (code 414.1), reported in 40 patients (8.5%), 
followed by pericarditis in 18 patients (3.8%), mitral valvuli-
tis in 2 patients (0.4%) and supraventricular tachycardia in 1 
patient. The vast majority of cases with CAA occurred in chil-
dren younger than 5 years of age (n = 35 patients, 87.5%; mean 
age: 1.93 years; SD: 1.92) and in the subgroup of children 1–4 
years of age (n = 21 patients, 52.5%; mean age: 1.24 years; 
SD: 0.98). Gender distribution was significantly different with 
a male-to-female ratio of 3.4:1 in the whole group (3.7/1 for 
infants <1 year; 3.2/1 and 4/1 for children 1–4 and 5–9 years 
of age, respectively). The territorial distribution was similar to 
that of the general cohort.
There were 2 deaths (0.4%): male infants 14 and 21 months 
of age died in 2007 and 2011, respectively, in the Lisbon region. 
The cause of death was attributed to myocardial infarction. Both 
patients had multiple coronary aneurysms and resistance to con-
ventional treatment.
Incidence Rates
Based on the Census data from 2011 provided by Sta-
tistics Portugal, the mean annual incidences of KD in Portugal 
were calculated (Table 2).25 From 2000 to 2011, the incidence 
of KD was highest in children younger than 5 years (6.48 per 
100,000 children; 95% CI: 7.4–5.6; ranging from 3.8 to 8.3), 
followed by children between 5 and 9 years of age (1.1 per 
100,000 children) and almost null for older patients. Consid-
ering the general population, the incidence of KD is 1.9 per 
100,000 individuals.
TABLE 1. Hospitalized Patients With Kawasaki 
Disease in Portugal; Distribution per Year and Region
Year
Portuguese Regions
Total (%)Alentejo Algarve Centro Lisbon North
2000 1 1 5 37 3 47 (10.0)
2001 1 2 3 20 4 30 (6.4)
2002 1 2 8 17 5 33 (7.0)
2003 1 2 4 18 5 30 (6.4)
2004 2 3 9 27 9 50 (10.6)
2005  2 7 25 9 43 (9.1)
2006 1 1 8 23  33 (7.0)
2007 1 2 5 26 9 43 (9.1)
2008   9 22 15 46 (9.8)
2009 1 2 8 22 6 39 (8.3)
2010 1  6 16 8 31 (6.6)
2011  2 10 24 9 45 (9.6)
Total (%) 10 (2.1) 19 (4.0) 82 (17.5) 277 (58.9) 82 (17.5) 470
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When we stratified children under 5 years of age into 2 sub-
groups, infants under 1 year of age and children between 1 and 4 
years of age, we obtained an incidence of 4.5 (95% CI: 5.44–3.54) 
and 7.8 (95% CI: 8.97–6.63) per 100,000, respectively.
The incidence of KD was significantly higher in boys, with 
the highest rate occurring in male infants under 1 year of age (11.4 
per 100,000; 95% CI: 14.32–8.34) when compared with female 
infants of the same age (6.5 per 100,000; 95% CI: 7.98–5.02). The 
male predominance is constant in all age groups, although with 
smaller differences (Table 3).
The incidence of KD was higher in the regions with a higher 
density of population, like Lisbon, an exception in the North 
region. Considering the group of children under 5 years, the high-
est incidence was in Lisbon region with 13.0 per 100,000 children, 
followed by Algarve and Center regions with an incidence of 6.3 
and 5.2 per 100,000 children, respectively (Table 4).
DISCUSSION
This is the first large-scale epidemiologic study of KD in 
Portugal, which provides a national estimate of hospitalizations 
associated with physician-diagnosed KD among Portuguese chil-
dren and estimates of patients. This study revealed a mean annual 
incidence of 6.48 per 100,000 children under 5 years of age from 
2000 through 2011. As expected, this incidence is very different 
from the highest incidences observed in Japan and other Asian 
countries, which favors the genetic theory for KD etiology. The 
mean incidence varied between 3.75 and 7.97 during our 12-year 
study period. These incidences fall within the range from 3.6 to 15.2 
reported in other European studies, for Caucasians (Table, Supple-
mental Digital Content 2, http://links.lww.com/INF/C615 which 
shows the annual incidence of KD in different European countries). 
There was some stability in the number of cases per year, with a 
mean of 39 cases per year, although there was evidence of some 
periodic peaks of incidence, as other authors have also reported, 
aspect that supports the infectious etiology. The data of this study 
also suggest that the incidence of KD has not remarkably changed 
during the study period, as also reported by other authors.26–36
The mean incidence found to occur in the current study 
could be underestimated, taking into account several factors such 
as the methodology, the retrospective nature of the coding system 
and the probability of some cases not being correctly coded. In 
addition, atypical cases may have been missed because of the pub-
lic health system in Portugal, where general practitioners examine 
children before referral to the pediatrician. Although general prac-
titioners follow national guidelines to contact a pediatrician after 5 
days of persistent fever (earlier in infants and very young children), 
missing cases of KD because of unawareness of this rare disease 
is likely to occur. In addition, pediatricians may also have under-
diagnosed KD because of the obvious resemblance with infectious 
disease and the lack of any specific diagnostic test. We, therefore, 
believe that the incidence of 6.48 per 100,000 children <5 years of 
age should be taken as a minimum estimate of the true incidence 
of KD in Portugal.
KD rates were higher in younger children (6.48 per 100,000 
children under 5 years) with a mean age of 2.8 years; male infants 
and children are more prone to the disease than female pediatric 
population with a mean ratio of 1.6:1 (varying from 1.8/1 and 
1.4/1). The highest rate occurred in male infants under 1 year of 
age, with an incidence rate almost double when compared with 
female infants of the same age (11.4 vs. 6.5 per 100,000).
Cardiac involvement and mortality were also within the 
expected rates. The incidence of CAA was significantly higher 
among boys, with a male-to-female ratio of 3.4:1. Coronary aneu-
rysms occurred mainly in male children under 5 years of age. Mor-
tality occurred in 2 male infants because of myocardial infarction, 
which corroborates a more severe outcome in male infants, as 
reported previously.26–36
A remarkable finding of our study is that the incidence rate is 
related to the population density, which varies throughout the coun-
try. Differences in the incidence of KD were found to occur between 
TABLE 2. Incidence of Kawasaki Disease in Portuguese 
Population Stratified by Age Groups and Subgroups and 
by Year
Year <1 yr 1–4 yr <5 yr 5–9 yr 10–14 yr 15–19 yr Total
2000 4.69 10.16 7.91 0.77 0.37 0.00 2.11
2001 3.26 5.15 4.38 1.36 0.00 0.00 1.36
2002 4.69 5.66 5.27 0.97 0.00 0.00 1.51
2003 2.82 4.37 3.75 1.76 0.00 0.17 1.39
2004 8.66 8.13 8.33 0.77 0.37 0.00 2.34
2005 3.90 7.63 6.16 2.10 0.00 0.00 2.03
2006 4.95 6.11 5.66 0.57 0.19 0.00 1.57
2007 5.63 8.80 7.56 0.76 0.19 0.00 2.05
2008 4.12 10.98 8.29 0.57 0.39 0.00 2.21
2009 3.66 8.49 6.59 1.35 0.00 0.00 1.89
2010 2.14 8.41 5.92 0.40 0.00 0.19 1.52
2011 5.40 9.68 7.97 1.42 0.19 0.00 2.24
Average 4.49 7.80 6.48 1.07 0.14 0.09 1.85




<1 yr 1–4 yr 5–9 yr 10–14 yr 15–19 yr <1 yr 1–4 yr 5–9 yr 10–14 yr 15–19 yr
2000 8.92 8.04 0.75 0.36 0.00 9.61 7.04 0.79 0.38 0.00
2001 7.28 6.02 0.38 0.00 0.00 5.86 1.48 2.40 0.00 0.00
2002 14.35 4.12 1.51 0.00 0.00 3.85 4.39 0.40 0.00 0.00
2003 7.31 5.44 2.28 0.00 0.00 3.92 0.97 1.21 0.00 0.35
2004 26.53 7.75 0.75 0.37 0.00 7.99 4.38 0.80 0.38 0.00
2005 9.39 7.46 1.86 0.00 0.00 6.03 3.96 2.35 0.00 0.00
2006 9.84 5.17 1.11 0.00 0.00 10.31 3.99 0.00 0.39 0.00
2007 14.14 8.16 1.48 0.38 0.00 8.52 5.06 0.00 0.00 0.00
2008 11.88 7.89 1.11 0.38 0.00 4.19 8.79 0.00 0.40 0.00
2009 8.38 4.49 1.88 0.00 0.00 6.53 9.36 0.79 0.00 0.00
2010 6.22 8.80 0.00 0.00 0.00 2.12 3.80 0.82 0.00 0.38
2011 12.92 9.97 1.18 0.37 0.00 9.05 4.37 1.66 0.00 0.00
Total 11.43 6.94 1.19 0.15 0.00 6.50 4.71 0.94 0.13 0.06
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different territorial regions of Portugal, with the highest incidences 
found in the most densely populated provinces. Urbanization, indus-
trialization and higher socioeconomic status have previously been sug-
gested to be related to the occurrence of KD, which may be related to 
important sociocultural differences between the highly populated areas, 
such as Lisbon, and the agricultural regions in Portugal, like the north-
ern and the southern ones. It is also possible that differences in inci-
dences between territories could be because of differences in scientific 
awareness about KD diagnosis that prevails in these territories
This study has some limitations. The number of KD-asso-
ciated hospitalizations could have been underestimated because of 
inclusion of misdiagnosed cases as KD or no inclusion of cases that 
were not hospitalized. Some data were unavailable, such as race/
ethnicity, clinical characteristics, like duration of fever, therapeu-
tics or other complications that might not have been coded.37
A unique feature of this study was the use of the national 
database of DRG classification system. This national database of 
hospitalized patients, with coded diagnosis and procedures, is in 
use in Portugal since 1990, is mandatory for all hospital discharged 
patients. The use of these data was demonstrated in other studies as 
adequate to generate solid national estimates of hospitalizations of 
both rare and common diseases in all age groups, representing an 
important tool for epidemiologic studies to estimate national hospi-
talization data10,23,28,32,37. The usefulness and adequacy of this method-
ology to estimate KD epidemiology in Portugal was demonstrated.
The epidemiologic data reported by this study is consistent 
with similar European studies on Caucasians, specifically the pre-
dilection for younger children and male predominance. As the first 
Portuguese study, it might serve as a useful tool for further clinical 
and epidemiologic studies.
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Update on Zika: What You Need to Know: ERRATUM
In the article on page 333, volume 36, issue 3, the incorrect version of Figure 1 was included. The final and 
author-approved version of Figure 1 appears below.
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FIGURE 1. Countries, territories and areas showing the distribution of Zika virus, 2013–2016. 
